Monthly Archives: April 2020
Virtual Shade Tree Trot to be held this Saturday
The annual Shade Tree Trot, a vital and longstanding fundraising event for the Shade Tree Clinic, has been canceled due to COVID-19. In place of the 5K race, there will be a Virtual Shade Tree Trot, open to the public. Continue reading
Study launched to test hydroxychloroquine as treatment for COVID-19
Vanderbilt University Medical Center is leading a clinical trial to understand if hydroxychloroquine, a well-known drug used for malaria and rheumatologic conditions, is safe and effective in treating hospitalized adults with COVID-19. Continue reading
Deadline extended for 2020 Administrative Professional Award nominations
The award is presented each year during a professional development event and appreciation reception that highlights the contributions of the Medical Center’s administrative professionals. Continue reading
‘COVID-19 Update through a Public Health Lens’ virtual event is tomorrow
New vumc2go workforce app features make navigation easier
A new mobile app, vumc2go, connects members of the Vanderbilt University Medical Center community to current COVID-19 news and updates with just a few taps of the finger. Continue reading
“Discover”: New tool to pinpoint stroke risk in sickle cell disease
“Kudos Wall” in Children’s Hospital offers messages of hope and encouragement
“We decided that the opportunity to ‘throw kindness like confetti’ would be an enjoyable way for staff to interact with and encourage one another through the stresses of this season in the health care system.” Continue reading
Self-care crucial for providers during pandemic
High levels of stress and anxiety can be debilitating, especially for health care providers on the front lines of the COVID-19 pandemic. But there are ways they can protect themselves and their ability to provide the best and most compassionate care. Continue reading
New Health Plus guide: How to stay healthy and productive while working remotely
VUMC and AstraZeneca join forces to identify potential COVID-19 treatments
Under a recently signed agreement, genetic sequences for antibodies discovered in the Vanderbilt Vaccine Center will be provided to AstraZeneca for identification of the most promising candidates for clinical assessment and future clinical use. Continue reading